ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
Equity - Authorised | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
Equity - Issued | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
Equity Paid Up | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹3.29 Cr | ₹2.57 Cr | ₹1.95 Cr | ₹1.59 Cr | ₹1.59 Cr |
Total Reserves | ₹704 Cr | ₹581 Cr | ₹504 Cr | ₹450 Cr | ₹358 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | ₹72 Cr | ₹72 Cr | ₹72 Cr | ₹72 Cr | ₹72 Cr |
Profit & Loss Account Balance | ₹578 Cr | ₹456 Cr | ₹379 Cr | ₹324 Cr | ₹232 Cr |
General Reserves | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹704 Cr | ₹581 Cr | ₹504 Cr | ₹450 Cr | ₹358 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹712 Cr | ₹589 Cr | ₹511 Cr | ₹456 Cr | ₹364 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr | ₹-15 Cr |
Deferred Tax Assets | ₹22 Cr | ₹22 Cr | ₹18 Cr | ₹17 Cr | ₹17 Cr |
Deferred Tax Liability | ₹1.06 Cr | ₹1.53 Cr | ₹1.87 Cr | ₹2.78 Cr | ₹2.83 Cr |
Other Long Term Liabilities | ₹2.78 Cr | ₹3.69 Cr | ₹5.02 Cr | ₹8.63 Cr | ₹9.30 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹116 Cr | ₹86 Cr | ₹85 Cr | ₹51 Cr | ₹49 Cr |
Total Non-Current Liabilities | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr | ₹44 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹197 Cr | ₹228 Cr | ₹190 Cr | ₹178 Cr | ₹210 Cr |
Sundry Creditors | ₹197 Cr | ₹228 Cr | ₹190 Cr | ₹178 Cr | ₹210 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹111 Cr | ₹112 Cr | ₹94 Cr | ₹83 Cr | ₹71 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹111 Cr | ₹112 Cr | ₹94 Cr | ₹83 Cr | ₹71 Cr |
Short Term Borrowings | - | - | - | - | - |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | - | - |
Short Term Provisions | ₹160 Cr | ₹145 Cr | ₹108 Cr | ₹112 Cr | ₹86 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹121 Cr | ₹107 Cr | ₹69 Cr | ₹80 Cr | ₹46 Cr |
Provision for post retirement benefits | ₹1.06 Cr | ₹0.63 Cr | ₹0.54 Cr | ₹0.50 Cr | ₹5.44 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹38 Cr | ₹37 Cr | ₹38 Cr | ₹32 Cr | ₹35 Cr |
Total Current Liabilities | ₹467 Cr | ₹484 Cr | ₹392 Cr | ₹373 Cr | ₹367 Cr |
Total Liabilities | ₹1,277 Cr | ₹1,142 Cr | ₹977 Cr | ₹874 Cr | ₹776 Cr |
ASSETS | |||||
Gross Block | ₹187 Cr | ₹179 Cr | ₹169 Cr | ₹160 Cr | ₹133 Cr |
Less: Accumulated Depreciation | ₹120 Cr | ₹110 Cr | ₹94 Cr | ₹79 Cr | ₹61 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹67 Cr | ₹69 Cr | ₹74 Cr | ₹81 Cr | ₹72 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.27 Cr | ₹1.33 Cr | ₹2.20 Cr | ₹4.02 Cr | ₹24 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹167 Cr | ₹136 Cr | ₹135 Cr | ₹101 Cr | ₹98 Cr |
Other Non Current Assets | - | - | - | ₹0.01 Cr | ₹0.01 Cr |
Total Non-Current Assets | ₹234 Cr | ₹206 Cr | ₹212 Cr | ₹186 Cr | ₹193 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹228 Cr | ₹190 Cr | ₹140 Cr | ₹160 Cr | ₹165 Cr |
Raw Materials | ₹18 Cr | ₹15 Cr | ₹14 Cr | ₹20 Cr | ₹21 Cr |
Work-in Progress | ₹4.73 Cr | ₹1.67 Cr | ₹3.06 Cr | ₹3.74 Cr | ₹1.22 Cr |
Finished Goods | ₹44 Cr | ₹37 Cr | ₹39 Cr | ₹33 Cr | ₹23 Cr |
Packing Materials | ₹1.34 Cr | ₹1.51 Cr | ₹1.76 Cr | ₹2.14 Cr | ₹2.39 Cr |
Stores  and Spare | ₹1.74 Cr | ₹1.72 Cr | ₹1.77 Cr | ₹1.78 Cr | ₹1.60 Cr |
Other Inventory | ₹158 Cr | ₹133 Cr | ₹81 Cr | ₹100 Cr | ₹116 Cr |
Sundry Debtors | ₹153 Cr | ₹108 Cr | ₹86 Cr | ₹85 Cr | ₹83 Cr |
Debtors more than Six months | ₹15 Cr | ₹9.64 Cr | ₹10 Cr | ₹6.81 Cr | - |
Debtors Others | ₹160 Cr | ₹115 Cr | ₹91 Cr | ₹89 Cr | ₹92 Cr |
Cash and Bank | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr | ₹253 Cr |
Cash in hand | - | - | - | - | - |
Balances at Bank | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr | ₹253 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹13 Cr | ₹14 Cr | ₹13 Cr | ₹9.84 Cr | ₹10 Cr |
Interest accrued on Investments | ₹2.27 Cr | ₹1.79 Cr | ₹1.82 Cr | ₹1.45 Cr | ₹1.84 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹11 Cr | ₹12 Cr | ₹11 Cr | ₹8.39 Cr | ₹8.28 Cr |
Other current_assets | - | - | - | - | - |
Short Term Loans and Advances | ₹143 Cr | ₹124 Cr | ₹78 Cr | ₹82 Cr | ₹71 Cr |
Advances recoverable in cash or in kind | ₹1.01 Cr | ₹0.65 Cr | ₹1.27 Cr | ₹0.55 Cr | ₹1.29 Cr |
Advance income tax and TDS | ₹110 Cr | ₹100 Cr | ₹60 Cr | ₹70 Cr | ₹40 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹32 Cr | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹30 Cr |
Total Current Assets | ₹1,043 Cr | ₹936 Cr | ₹765 Cr | ₹689 Cr | ₹582 Cr |
Net Current Assets (Including Current Investments) | ₹576 Cr | ₹452 Cr | ₹373 Cr | ₹315 Cr | ₹215 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,277 Cr | ₹1,142 Cr | ₹977 Cr | ₹874 Cr | ₹776 Cr |
Contingent Liabilities | ₹138 Cr | ₹132 Cr | ₹123 Cr | ₹86 Cr | ₹67 Cr |
Total Debt | - | - | - | - | - |
Book Value | 283.45 | 234.45 | 203.78 | 181.83 | 145.14 |
Adjusted Book Value | 283.45 | 234.45 | 203.78 | 181.83 | 145.14 |
Compare Balance Sheet of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹18,319.1 Cr | 13.3% | 12.6% | 13.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 3.7% | 8.5% | 49.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 3.6% | 1.8% | 52.1% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 3% | 1.9% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 2.7% | 15.5% | 23.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -1.6% | 1% | 43.9% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 13.3% |
12.6% |
13.3% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses